BioCryst Pharmaceuticals Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| CSL | CSL | Outperform |
12
|
$280.64 | Buy/Sell | $205.51 | -26.79% | 5 | $135.62B |
| 4568 | Daiichi Sankyo Company | Buy |
4
|
¥5.63k | Buy/Sell | ¥5.24k | 10.18% | 0 | ¥10.79T |
| 4502 | Takeda Pharmaceutical Company | Outperform |
5
|
¥4.13k | Buy/Sell | ¥4.74k | 11.35% | 0 | ¥6.48T |
| BMRN | BioMarin Pharmaceutical | Outperform |
10
|
$75.52 | Buy/Sell | $111.56 | 46.32% | 5 | $14.62B |
| 4507 | Shionogi & | Outperform |
18
|
¥6.92k | Buy/Sell | ¥7.12k | 15.59% | 0 | ¥2.16T |
| IONS | Ionis Pharmaceuticals | Outperform |
9
|
$37.28 | Buy/Sell | $55.60 | 60.94% | 3 | $5.76B |
| NTLA | Intellia Therapeutics | Outperform |
8
|
$24.84 | Buy/Sell | $75.84 | 181.80% | 21 | $2.36B |
| PHARM | Pharming Group N.V. | Buy |
16
|
0.83€ | Buy/Sell | 1.85€ | 146.99% | 2 | 591.95€M |
| KALV | KalVista Pharmaceuticals | Buy |
7
|
$11.30 | Buy/Sell | $20.80 | 209.73% | 0 | $478.84M |